Hepatitis C News

A simplified, rapid treatment model for hepatitis C virus improved cure rates and the cascade of care among young people who inject drugs, according to a recent study.

Patients with hepatitis C who achieved sustained virologic response through direct-acting antiviral therapy experienced a decrease in psychiatric hospitalizations after treatment, according to a presenter at The Liver Meeting Digital Experience.

In 2019, only 32% of children and youth who had tested positive for hepatitis C in British Columbia, Canada, had initiated treatment, according to data presented at The Liver Meeting Digital Experience.

During the 2021 match cycle, a presence on Twitter and having specialized training tracks were associated with a higher likelihood of filling infectious disease fellowships programs, researchers found.

When treated with direct-acting antiviral therapy, patients with chronic hepatitis C virus infection were at a lower risk for end-stage kidney disease and the composite of ESKD or death, according to a speaker at ASN Kidney week.

HIV captured me during my first clinical rotation in medical school, early in the Plague Years, around the same time that AIDS was getting its name from CDC.

Tenofovir alafenamide therapy was safe, well-tolerated and prevented the transmission of hepatitis B virus from pregnant mothers to infants, according to research presented at The Liver Meeting Digital Experience.

Consultations, testing and treatment of hepatitis B and C virus fell significantly during the first year of the COVID-19 pandemic, with many centers seeing declines of more than 75% in all categories, according to a presentation.

Compared to current practices of annual screening for hepatitis C virus in men who have sex with men, working toward reducing their risk and screening every 6 months could prove cost effective, according to a presentation.

Higher end-of-treatment hepatitis B e-antigen level correlated with nucleos(t)ide clinical relapse but did not correlate with relapse severity regardless of HBsAg level among patients with chronic hepatitis B virus, according to research.